Hiram Tendilla-Beltrán
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hiram Tendilla-Beltrán has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Gonzalo Flores
Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla 72570, Mexico
28 shared publications - Rubén Antonio Vázquez-Roque
Institute of Physiology, Benemerita Universidad Autonoma de Puebla (BUAP), Puebla 72590, Mexico
7 shared publications - David Martín-Hernández
Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense Madrid (UCM); Research Institute of Hospital 12 de Octubre (Imas12); University Institute of Research in Neurochemistry of the UCM (IUIN-UCM), Madrid, Spain
6 shared publications - Juan Carlos Leza
Department of Pharmacology and Toxicology, Faculty of Medicine, University Complutense Madrid (UCM); Research Institute of Hospital 12 de Octubre (Imas12); University Institute of Research in Neurochemistry of the UCM (IUIN-UCM), Madrid, Spain
5 shared publications - Julio César Morales-Medina
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Unidad Tlaxcala, Ixtacuixtla, 90120, Tlaxcala, México.
5 shared publications Patricia Aguilar-Alonso
Facultad de Ciencias Químicas, Benemérita Universidad Autónoma de Puebla (BUAP), Puebla, Mexico
5 shared publications
Latest Publications
- 14 November 2026
- Published by Springer Nature
- p. 1-25
Neuroinflammation and Postmortem Samples in Alcohol Use Disorder: Immunohistochemistry Biomarkers
- 14 November 2026
- Published by Springer Nature
- p. 1-25
Neuroinflammation and Postmortem Samples in Alcohol Use Disorder: Immunohistochemistry Biomarkers
- Open Access
- 29 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9700
Hippocampal Glial Alterations Are Associated with Mitochondrial Changes and Reduced Glucocorticoid Receptor Density in Suicides
Suicide is a major public health concern frequently associated with depressive disorders and neurobiological alterations within the hippocampus. This study investigated biomarkers related to neuroinflammation, oxidative/nitrosative stress, and mitochondrial labeling in the CA1 region of the hippocampus of young and adult individuals of Mexican ancestry who died by suicide. Postmortem hippocampal CA1 samples were obtained from young and adult suicide cases and age-matched controls. Cellular markers of microglia (ionized calcium-binding adapter molecule 1, Iba1) and astrocytes (glial fibrillary acidic protein, GFAP), neuronal density, glucocorticoid receptor expression, and mitochondrial labeling were evaluated and compared among groups. Suicide cases exhibited increased microglial and astrocyte cell density indicated by increased Iba1 and GFAP immunoreactivity in both age groups. In contrast, mitochondrial labeling and glucocorticoid receptor immunoreactivity were reduced in suicide cases, regardless of age. Additionally, a significant reduction in neuronal density was detected exclusively in young individuals who died by suicide. Together, these findings indicate age-independent alterations in glial immunoreactivity, mitochondrial labeling, and glucocorticoid receptor expression, alongside reduced neuronal density in the hippocampal CA1 region of younger suicide cases, supporting the involvement of neuroinflammation-related processes in suicide. Despite the limited sample size, these findings provide insight into potential neurobiological mechanisms underlying suicide and may contribute to the identification of biomarkers and therapeutic targets for individuals at risk.
- 29 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9700
Open AccessHippocampal Glial Alterations Are Associated with Mitochondrial Changes and Reduced Glucocorticoid Receptor Density in Suicides
Suicide is a major public health concern frequently associated with depressive disorders and neurobiological alterations within the hippocampus. This study investigated biomarkers related to neuroinflammation, oxidative/nitrosative stress, and mitochondrial labeling in the CA1 region of the hippocampus of young and adult individuals of Mexican ancestry who died by suicide. Postmortem hippocampal CA1 samples were obtained from young and adult suicide cases and age-matched controls. Cellular markers of microglia (ionized calcium-binding adapter molecule 1, Iba1) and astrocytes (glial fibrillary acidic protein, GFAP), neuronal density, glucocorticoid receptor expression, and mitochondrial labeling were evaluated and compared among groups. Suicide cases exhibited increased microglial and astrocyte cell density indicated by increased Iba1 and GFAP immunoreactivity in both age groups. In contrast, mitochondrial labeling and glucocorticoid receptor immunoreactivity were reduced in suicide cases, regardless of age. Additionally, a significant reduction in neuronal density was detected exclusively in young individuals who died by suicide. Together, these findings indicate age-independent alterations in glial immunoreactivity, mitochondrial labeling, and glucocorticoid receptor expression, alongside reduced neuronal density in the hippocampal CA1 region of younger suicide cases, supporting the involvement of neuroinflammation-related processes in suicide. Despite the limited sample size, these findings provide insight into potential neurobiological mechanisms underlying suicide and may contribute to the identification of biomarkers and therapeutic targets for individuals at risk.
- Open Access
- 28 February 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (11) , 5222-5223
Dendritic spine research: Next frontier in the age of artificial intelligence
An abstract is unavailable. This article is available as a PDF only.
- 28 February 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (11) , 5222-5223
Open AccessDendritic spine research: Next frontier in the age of artificial intelligence
An abstract is unavailable. This article is available as a PDF only.
- 28 November 2025
- Published by Elsevier in Neuroscience
- Vol. 592, 223-231
Quetiapine treatment corrects behavioral impairments and promotes neuroplasticity in a neurodevelopmental rat model of schizophrenia
- 28 November 2025
- Published by Elsevier in Neuroscience
- Vol. 592, 223-231
Quetiapine treatment corrects behavioral impairments and promotes neuroplasticity in a neurodevelopmental rat model of schizophrenia
- Open Access
- 27 July 2025
- Published by Elsevier in Neuroscience
- Vol. 583, 23-32
Alterations in dendritic spine plasticity in the prefrontal cortex induced by social play restrictions in male rats
- 27 July 2025
- Published by Elsevier in Neuroscience
- Vol. 583, 23-32
Open AccessAlterations in dendritic spine plasticity in the prefrontal cortex induced by social play restrictions in male rats
- Open Access
- 14 May 2025
- Published by Elsevier in Neurobiology of Sleep and Circadian Rhythms
- Vol. 18 (Suppl) , 100126
Effect of chronic sleep restriction on ethanol preference and cortical structural plasticity
- 14 May 2025
- Published by Elsevier in Neurobiology of Sleep and Circadian Rhythms
- Vol. 18 (Suppl) , 100126
Open AccessEffect of chronic sleep restriction on ethanol preference and cortical structural plasticity
- Open Access
- 13 August 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1446255
Dysregulated zinc homeostasis and microadenomas in the anterior pituitary: pathological insights into suicide risk
Background: Suicide is a significant public health problem influenced by various risk factors, including dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis. Zinc (Zn), essential for pituitary function in hormone synthesis and release, has been linked to suicide, with studies noting reduced serum levels and altered brain transport mechanisms. Despite Zn’s crucial role in pituitary function and its involvement in suicidal behavior, information on pituitary Zn in suicide is scarce. Tumor cells modify Zn dynamics in tissues, and a previous report suggests microadenomas in the anterior pituitary as a risk factor for suicide.Methods: Histopathological analysis with hematoxylin-eosin stain and histochemical techniques to assess Zn homeostasis were carried out on anterior pituitary postmortem samples from 14 suicide completers and 9 non-suicidal cases.Results: Pituitary microadenomas were identified in 35% of suicide cases and none in the non-suicidal cases. Furthermore, compartmentalized Zn (detected via dithizone reactivity), but not free Zn levels (detected via zinquin reactivity), was lower in the suicide cases compared to the non-suicidal group.Conclusion: This is the first report of a potential association between disrupted Zn homeostasis and microadenomas in the anterior pituitary as a feature in suicide and provides critical insights for future neuroendocrine Zn-related research.
- 13 August 2024
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 15, 1446255
Open AccessDysregulated zinc homeostasis and microadenomas in the anterior pituitary: pathological insights into suicide risk
Background: Suicide is a significant public health problem influenced by various risk factors, including dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis. Zinc (Zn), essential for pituitary function in hormone synthesis and release, has been linked to suicide, with studies noting reduced serum levels and altered brain transport mechanisms. Despite Zn’s crucial role in pituitary function and its involvement in suicidal behavior, information on pituitary Zn in suicide is scarce. Tumor cells modify Zn dynamics in tissues, and a previous report suggests microadenomas in the anterior pituitary as a risk factor for suicide.Methods: Histopathological analysis with hematoxylin-eosin stain and histochemical techniques to assess Zn homeostasis were carried out on anterior pituitary postmortem samples from 14 suicide completers and 9 non-suicidal cases.Results: Pituitary microadenomas were identified in 35% of suicide cases and none in the non-suicidal cases. Furthermore, compartmentalized Zn (detected via dithizone reactivity), but not free Zn levels (detected via zinquin reactivity), was lower in the suicide cases compared to the non-suicidal group.Conclusion: This is the first report of a potential association between disrupted Zn homeostasis and microadenomas in the anterior pituitary as a feature in suicide and provides critical insights for future neuroendocrine Zn-related research.
- Open Access
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1278748
Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action
Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action
- 1 September 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1278748
Open AccessEditorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action
Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action
- Open Access
- 10 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (16) , 12634
Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
Over the past few decades, extensive research has shed light on immune alterations and the significance of dysfunctional biological barriers in psychiatric disorders. The leaky gut phenomenon, intimately linked to the integrity of both brain and intestinal barriers, may play a crucial role in the origin of peripheral and central inflammation in these pathologies. Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates both the immune response and the permeability of biological barriers. Notably, S1P-based drugs, such as fingolimod and ozanimod, have received approval for treating multiple sclerosis, an autoimmune disease of the central nervous system (CNS), and ulcerative colitis, an inflammatory condition of the colon, respectively. Although the precise mechanisms of action are still under investigation, the effectiveness of S1P-based drugs in treating these pathologies sparks a debate on extending their use in psychiatry. This comprehensive review aims to delve into the molecular mechanisms through which S1P modulates the immune system and brain/intestinal barrier functions. Furthermore, it will specifically focus on psychiatric diseases, with the primary objective of uncovering the potential of innovative therapies based on S1P signaling.
- 10 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (16) , 12634
Open AccessImmune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?
Over the past few decades, extensive research has shed light on immune alterations and the significance of dysfunctional biological barriers in psychiatric disorders. The leaky gut phenomenon, intimately linked to the integrity of both brain and intestinal barriers, may play a crucial role in the origin of peripheral and central inflammation in these pathologies. Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates both the immune response and the permeability of biological barriers. Notably, S1P-based drugs, such as fingolimod and ozanimod, have received approval for treating multiple sclerosis, an autoimmune disease of the central nervous system (CNS), and ulcerative colitis, an inflammatory condition of the colon, respectively. Although the precise mechanisms of action are still under investigation, the effectiveness of S1P-based drugs in treating these pathologies sparks a debate on extending their use in psychiatry. This comprehensive review aims to delve into the molecular mechanisms through which S1P modulates the immune system and brain/intestinal barrier functions. Furthermore, it will specifically focus on psychiatric diseases, with the primary objective of uncovering the potential of innovative therapies based on S1P signaling.
- 21 July 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 132, 102316
Aripiprazole attenuates the medial prefrontal cortex morphological and biochemical alterations in rats with neonatal ventral hippocampus lesion
- 21 July 2023
- Published by Elsevier in Journal of Chemical Neuroanatomy
- Vol. 132, 102316
Aripiprazole attenuates the medial prefrontal cortex morphological and biochemical alterations in rats with neonatal ventral hippocampus lesion